跳至主要内容
临床试验/JPRN-C000000367
JPRN-C000000367已完成未知

Multicentric study of combination therapy of theophylline and tiotropium in COPD - Theophylline and tiotropium in COPD

Graduate school of biomedical sciences, Hiroshima university, department of molecular and internal medicine0 个研究点目标入组 100 人开始时间: 2006年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients for whom theophylline or tiotropium is contraindicated Patients who have used other long acting bronchodilator, other xanthine, and inhaled corticosteroid within 1 month Patients with asthma Patients who need persistant oxygen therapy Patients with respiratory infection within 1 month Patients with severe hepatic, renal, heart, hematologic abnormality Patients with active tuberculosis or pulmonary sequelae of tuberculosis Patients with cancer within 2 years. (excluding basal cell carcinoma) Patients with cystic fibrosis and bronchiectasis Patients who are or could be pregnant In addition to the above exclusion criteria, patients judged to be inadequate to participate in this study by their physician

研究者

发起方
Graduate school of biomedical sciences, Hiroshima university, department of molecular and internal medicine

相似试验